Improved Physical, Emotional, and Social Well-Being in People Living With Obesity Treated With Semaglutide: A Plain Language Summary.
Ther Adv Endocrinol Metab · 2026
Last updated 2026-08-28| Journal | Ther Adv Endocrinol Metab, 2026 |
|---|---|
| Citations | 0 |
| Molecules | semaglutide |
Abstract
What is this summary about? Many people live with extra weight or obesity. Semaglutide is a type of weight loss medication for the treatment of obesity. A study published in 2024 reported on the experiences of people taking semaglutide. People living with obesity who took semaglutide had improvements in their physical, emotional, and social health. Sharing the experiences of people taking weight loss medications may help others make important treatment decisions. What is the purpose of this plain language summary? Semaglutide is an approved medication for weight loss. In a recent study, people who lost weight while taking semaglutide had improved physical, mental, and social health. The goal of this summary is to share the study results in accessible language so that people living with obesity can make informed decisions about whether a medication for weight loss is right for them.
Verbatim abstract via PubMed 42110523 ↗
Related research
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity.
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.